Centuria Industrial REIT (ASX:CIP) settles Arnott’s properties in Queensland

  • Home
  • Company News
  • Centuria Industrial REIT (ASX:CIP) settles Arnott’s properties in Queensland
27Dec

Centuria Industrial REIT (ASX:CIP) settles Arnott’s properties in Queensland

 

Centuria Property Funds No. 2, as Responsible Entity of Centuria Industrial REIT (ASX:CIP) is pleased to confirm settlement of two industrial assets via a sale and leaseback with biscuit maker Arnotts.

The acquisition of two high quality industrial assets was for $236 million.

They are located at 46 Robinson Road East, Virginia QLD and 23-41 Galway Avenue, Marleston SA.

Shares in Centuria Industrial REIT (ASX:CIP) closed flat at $3.42.

Copyright 2019 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

16Jun

Starpharma (ASX:SPL) launches VivaGel in Europe

16 Jun 2020 - Starpharma (ASX:SPL) today announced that VivaGel BV has been launched in Central and Eastern European region.

Read More
09Jun

Stocks of the Hour: Charger Metals, Lithium Australia, Race Oncology, Syrah Resources

09 Jun 2022 - A snapshot of the stocks on the move featuring, Charger Metals (ASX:CHR) and Lithium Australia (ASX:LIT), Race Oncology (ASX:RAC), and Syrah Resources (ASX:SYR).

Read More
28Mar

Stocks of the Hour: WA1 Resources, Allup Silica, Dynamic Group Holdings

28 Mar 2024 - A snapshot of the stocks on the move, featuring WA1 Resources Ltd (ASX:WA1), Allup Silica (ASX:APS) and Dynamic Group Holdings (ASX:DDB).

Read More
03Aug

Monadelphous (ASX:MND) joint venture Zenviron wins $80 million GE wind farm contract

03 Aug 2020 - Zenviron, a Monadelphous (ASX:MND) joint venture, has won an $80 million contract with General Electric to build a wind farm in Victoria.

Read More
15Nov

Zeta Resources (ASX:ZER) refuses to accept takeover offer for Panoramic Resources (ASX:PAN)

15 Nov 2019 - Zeta Resources (ASX:ZER), which holds a stake of around 35.2 per cent in Panoramic Resources has signalled that it does not intend to accept Independence Group’s current takeover offer.

Read More
02Jan

Mesoblast (ASX:MSB) files positive clinical efficacy and safety data

02 Jan 2020 - Cellular medicinal provider, Mesoblast (ASX:MSB, NASDAQ:MESO) has lodged positive clinical efficacy and safety data with the US FDA for its lead product candidate, remestemcel-L.

Read More
28May

Mesoblast (ASX:MSB) reports a net loss US$45.3 million for nine months

28 May 2020 - Mesoblast (ASX:MSB), the company that develops cellular medicines for inflammatory diseases, has reported a net loss of $US45.3 million in the nine months to the end of March.

Read More
16Apr

Mayne Pharma (ASX:MYX) receives FDA approval for contraceptive pill

16 Apr 2021 - Specialty pharmaceutical company Mayne Pharma (ASX:MYX) has successfully received approval from the US Food and Drug Administration (FDA) for its product NEXTSTELLIS.

Read More
22Feb

Westgold Resources (ASX:WGX) report 552% increase in net profit before tax

22 Feb 2021 - Westgold Resources (ASX:WGX) report an impressive 552 per cent increase in net profit before income tax to $69.8 million for the half year period.

Read More
26Jul

Stocks of the Hour: QX Resources, Antisense Therapeutics, West Wits Mining

26 Jul 2023 - A snapshot of the stocks on the move, featuring QX Resources (ASX:QXR), Antisense Therapeutics (ASX:ANP) and West Wits Mining (ASX:WWI).

Read More